Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
jFKk5AGaaG4hz7Y8
